[The effect of norkolut on immune system status in patients with dyshormonal myocardial dystrophy and hyperplastic processes of the uterus].

Use of norkolut in 34 patients with dyshormonal myocardiodystrophy per 10 mg from the 16-th through 25-th days of the menstrual cycle for 6 months favoured improvement of clinical, ECG-data, normalization of values of the immune system. Three months after discontinuation of norkolut restoration occurred of T gamma, A-RFC at the I phase of menstrual cycle while the content of B-lymphocytes remains reduced. At the II phase of the menstrual cycle one observed a reduction of the absolute content of T gamma-cells, A-RFC.